Lower aspirin doses combined with clopidogrel may reduce ischemic events in high risk patients
Lower Aspirin Doses May Be Safer for Patients After Minor Strokes
Researchers analyzed data from a trial involving patients with transient ischemic attack and minor stroke receiving dual antiplatelet therap…
Doctors found that taking a lower dose of aspirin with clopidogrel may reduce the risk of serious heart and brain events.
Imatinib achieves complete cytogenetic response in a pediatric patient with suspected chronic myeloid leukemia
Imatinib works for CML in child with high platelets
This case report describes a pediatric patient with isolated thrombocytosis who achieved a complete cytogenetic response to imatinib after f…
A child with high platelets and no response to standard therapy was found to have CML and responded to imatinib.
Extended DAPT with clopidogrel and aspirin reduces cardiovascular death, myocardial infarction, and stroke risk
Extended dual antiplatelet therapy lowers risks for heart disease patients
This randomized trial of 8250 patients with multivessel coronary artery disease found that extending dual antiplatelet therapy (DAPT) for an…
Patients with coronary artery disease may have lower risks of stroke and heart attack when taking two blood thinners for an extra year.
Apixaban reduces stroke and systemic embolism in patients with subclinical atrial fibrillation and an implantable cardiac monitor
Apixaban reduces stroke risk in patients with certain heart conditions
This randomized controlled trial evaluated 4012 patients with subclinical atrial fibrillation, including a cohort of 209 with an implantable…
A new analysis shows that apixaban may significantly lower stroke risks for patients with subclinical atrial fibrillation and specific cardi…
Dipyridamole combined with immunoglobulin and aspirin improves clinical efficacy in children with Kawasaki disease
Dipyridamole Combined with Aspirin Improves Outcomes for Kawasaki Disease
This meta-analysis of randomized controlled trials involving 1,594 children found that adding dipyridamole to immunoglobulin and aspirin sig…
Adding dipyridamole to standard immunoglobulin and aspirin treatment may improve clinical outcomes and speed up recovery for children with K…
General medical management improves medication adherence and lifestyle outcomes in older adults with type 2 diabetes
New management model improves medication use and health for seniors
This randomized controlled trial of 200 older adults with type 2 diabetes and atherosclerotic cardiovascular disease found that a general me…
A new personalized care plan helps older adults with diabetes and heart disease stay on their medications and improve their daily habits.
DAPT and aspirin show potential for managing minor acute ischemic stroke based on SUCRA rankings
Best stroke treatment may depend on your goal
This network meta-analysis of 26,176 patients evaluated 9 antithrombotic interventions for minor acute ischemic stroke. The analysis suggest…
For minor stroke, the best treatment varies by what matters most: quick recovery, preventing another stroke, or avoiding bleeding.
Tirofiban Adjunct Therapy Improves Outcomes in Patients with Inadequate Tenecteplase Response
Trial shows tirofiban improves outcomes for some stroke patients
Intravenous tirofiban significantly improves 90-day functional outcomes for acute ischemic stroke patients failing initial tenecteplase ther…
A new clinical trial suggests that adding tirofiban can improve recovery rates for certain types of stroke patients who do not respond well …
Apixaban Reduces Intracranial Bleeding Risk Compared To Aspirin In Patients With Cryptogenic Stroke And Atrial Cardiopathy Evidence
Trial shows apixaban reduces intracranial bleeding risk versus aspirin in cryptogenic stroke patients
In a multicenter randomized trial of 1,015 patients, apixaban demonstrated a significant reduction in intracranial hemorrhage compared to as…
A trial of 1,015 patients found apixaban caused fewer intracranial hemorrhages than aspirin, offering safety insights for those with cryptog…
Early dual antiplatelet therapy improves outcomes after ischaemic stroke thrombolysis
Stroke Patients Gain Better Recovery With Early Double Blood Thinner Combo
A Chinese trial found that starting aspirin and ticagrelor within six hours after thrombolysis boosted excellent functional outcomes at 90 d…
Adding a second blood thinner within hours helps more stroke patients regain full function without raising bleeding risks
Narrative review suggests precision interventions for preeclampsia phenotypes
At-a-Glance
This narrative review examines prevention strategies for preeclampsia in pregnant women. The authors note that standard low-dose aspirin eff…
Preeclampsia prevention is moving beyond aspirin for everyone, with new research showing that matching treatments to a woman's specific risk…
Tailored antiplatelet strategy showed no benefit over standard dual therapy in high-risk PCI patients
New heart drug plan failed to beat standard care for high-risk patients
This randomized clinical trial compared a tailored antiplatelet strategy involving early low-dose ticagrelor followed by late de-escalation …
Doctors tested a custom heart drug plan but found standard treatment still works best for high-risk patients